---
title: 'cIMPACT-NOW update 9: Recommendations on utilization of genome-wide DNA methylation
  profiling for central nervous system tumor diagnostics'
date: '2025-02-04'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39902391/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250204170852&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Genome-wide DNA methylation signatures correlate with and distinguish
  central nervous system (CNS) tumor types. Since the publication of the initial CNS
  tumor DNA methylation classifier in 2018, this platform has been increasingly used
  as a diagnostic tool for CNS tumors, with multiple studies showing the value and
  utility of DNA methylation-based classification of CNS tumors. A Consortium to Inform
  Molecular and Practical Approaches to CNS Tumor Taxonomy (cIMPACT-NOW) Working Group
  ...
disable_comments: true
---
Genome-wide DNA methylation signatures correlate with and distinguish central nervous system (CNS) tumor types. Since the publication of the initial CNS tumor DNA methylation classifier in 2018, this platform has been increasingly used as a diagnostic tool for CNS tumors, with multiple studies showing the value and utility of DNA methylation-based classification of CNS tumors. A Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy (cIMPACT-NOW) Working Group ...